FRACTYL HEALTH ($GUTS) posted quarterly earnings results for Q1 2026 on Tuesday, May 12th. The company reported earnings of -$0.13 per share, beating estimates of -$0.16 by $0.03. The company also reported revenue of $0, equaling estimates of $0 by $0.
Stock price change since market close: +5.0%
You can see Quiver Quantitative's $GUTS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
FRACTYL HEALTH Insider Trading Activity
FRACTYL HEALTH insiders have traded $GUTS stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $GUTS stock by insiders over the last 6 months:
- HARITH RAJAGOPALAN (Chief Executive Officer) purchased 10,416 shares for an estimated $19,998
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
FRACTYL HEALTH Hedge Fund Activity
We have seen 66 institutional investors add shares of FRACTYL HEALTH stock to their portfolio, and 29 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ROSALIND ADVISORS, INC. removed 4,614,269 shares (-92.3%) from their portfolio in Q4 2025, for an estimated $10,151,391
- MARSHALL WACE, LLP added 4,156,969 shares (+234.9%) to their portfolio in Q4 2025, for an estimated $9,145,331
- VANGUARD GROUP INC added 4,107,032 shares (+213.8%) to their portfolio in Q4 2025, for an estimated $9,035,470
- PALE FIRE CAPITAL SE added 3,209,942 shares (+inf%) to their portfolio in Q4 2025, for an estimated $7,061,872
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 2,100,000 shares (-84.0%) from their portfolio in Q4 2025, for an estimated $4,620,000
- ATOM INVESTORS LP added 1,883,018 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,142,639
- JANE STREET GROUP, LLC added 1,862,600 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,097,720
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
FRACTYL HEALTH Analyst Ratings
Wall Street analysts have issued reports on $GUTS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 11/21/2025
To track analyst ratings and price targets for FRACTYL HEALTH, check out Quiver Quantitative's $GUTS forecast page.
FRACTYL HEALTH Price Targets
Multiple analysts have issued price targets for $GUTS recently. We have seen 3 analysts offer price targets for $GUTS in the last 6 months, with a median target of $8.0.
Here are some recent targets:
- Joseph Pantginis from HC Wainwright & Co. set a target price of $8.0 on 04/24/2026
- Whitney Ijem from Canaccord Genuity set a target price of $8.0 on 03/26/2026
- Michael Ulz from Morgan Stanley set a target price of $2.0 on 01/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
